JOHN KIRKWOOD to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.179
-
IFN-a in the treatment of melanoma. J Immunol. 2012 Oct 15; 189(8):3789-93.
Score: 0.103
-
CD56dim CD16- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-a. Front Immunol. 2019; 10:14.
Score: 0.040
-
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma. J Clin Oncol. 2017 Dec 01; 35(34):3815-3822.
Score: 0.036